Citi Pharma Limited (PSX:CPHL)
Pakistan
· Delayed Price · Currency is PKR 89.70
+3.27 (3.78%)
At close: Dec 5, 2025
Citi Pharma Ratios and Metrics
Market cap in millions PKR. Fiscal year is July - June.
Millions PKR. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Market Capitalization | 20,493 | 19,184 | 6,511 | 4,875 | 7,457 | - | Upgrade
|
| Market Cap Growth | 95.42% | 194.63% | 33.55% | -34.62% | - | - | Upgrade
|
| Enterprise Value | 22,384 | 20,807 | 6,236 | 4,443 | 5,627 | - | Upgrade
|
| Last Close Price | 89.70 | 80.81 | 25.42 | 17.15 | 26.24 | - | Upgrade
|
| PE Ratio | 22.94 | 21.51 | 7.81 | 7.41 | 11.41 | - | Upgrade
|
| PS Ratio | 1.54 | 1.46 | 0.53 | 0.39 | 0.76 | - | Upgrade
|
| PB Ratio | 1.85 | 1.77 | 1.16 | 0.91 | 1.58 | - | Upgrade
|
| P/TBV Ratio | 1.85 | 1.77 | 1.16 | 0.91 | 1.58 | - | Upgrade
|
| P/FCF Ratio | - | - | 8.46 | - | - | - | Upgrade
|
| P/OCF Ratio | - | - | 4.87 | - | - | - | Upgrade
|
| EV/Sales Ratio | 1.68 | 1.58 | 0.50 | 0.36 | 0.57 | - | Upgrade
|
| EV/EBITDA Ratio | 12.05 | 11.78 | 4.65 | 3.53 | 5.28 | - | Upgrade
|
| EV/EBIT Ratio | 13.30 | 12.97 | 5.17 | 3.81 | 5.66 | - | Upgrade
|
| EV/FCF Ratio | -25.04 | - | 8.11 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.25 | 0.27 | 0.26 | 0.34 | 0.20 | 0.07 | Upgrade
|
| Debt / EBITDA Ratio | 1.51 | 1.66 | 1.08 | 1.46 | 0.88 | 0.50 | Upgrade
|
| Debt / FCF Ratio | - | - | 1.89 | - | - | - | Upgrade
|
| Asset Turnover | 0.89 | 0.88 | 1.16 | 1.37 | 1.34 | 1.29 | Upgrade
|
| Inventory Turnover | 3.00 | 3.12 | 3.72 | 5.06 | 6.82 | 6.02 | Upgrade
|
| Quick Ratio | 0.66 | 0.66 | 0.68 | 0.80 | 1.15 | 1.92 | Upgrade
|
| Current Ratio | 1.36 | 1.30 | 1.36 | 1.48 | 1.86 | 2.45 | Upgrade
|
| Return on Equity (ROE) | 10.58% | 10.81% | 15.14% | 13.05% | 14.40% | 13.16% | Upgrade
|
| Return on Assets (ROA) | 7.00% | 6.71% | 7.03% | 8.06% | 8.49% | 7.96% | Upgrade
|
| Return on Capital (ROIC) | 9.94% | 9.59% | 10.54% | 11.34% | 12.01% | 11.62% | Upgrade
|
| Return on Capital Employed (ROCE) | 14.90% | 14.40% | 20.60% | 21.10% | 19.40% | 12.20% | Upgrade
|
| Earnings Yield | 4.36% | 4.65% | 12.80% | 13.50% | 8.77% | - | Upgrade
|
| FCF Yield | -4.36% | -2.45% | 11.82% | -26.33% | -12.38% | - | Upgrade
|
| Dividend Yield | 3.90% | 4.33% | 12.78% | 14.57% | - | - | Upgrade
|
| Payout Ratio | 82.73% | 82.94% | 68.53% | - | 47.66% | - | Upgrade
|
| Buyback Yield / Dilution | -0.14% | - | - | -0.70% | -21.65% | -88.38% | Upgrade
|
| Total Shareholder Return | 3.91% | 4.33% | 12.78% | 13.87% | -21.65% | -88.38% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.